2011 Annual Report - AASLD

award Recipients
• Oral (co-author): IL28B C/C genotype is
predictive of ≥ 1 log10 IU/mL reduction in
plasma HCV RNA after 4 weeks of peginterferon
(pegIFN) and ribavirin (RBV) therapy:
implications for the use of the lead-in strategy
for direct-acting antiviral-based treatment
regimens.
• Poster (PI): Metabolomic Analysis
Demonstrates Hepatitis C Virus Genotypes
G2/3 Selectively Perturb Distal Steps in
Cholesterol Biosynthesis
• Poster (co-author): Predictors of consent to
pharmacogenomics testing in the IDEAL study
• Poster (co-author): NK inhibitory receptor
expression associated with treatment failure
and IL-28B genotype in patients with chronic
hepatitis C
• Poster (co-author): Predicting
Peginterferon-α and Ribavirin treatment
response in genotype 1 HCV patients –
simple nomograms to support clinicians
• Poster(co-author): Vitamin D and Treatment
Response in African American Patients with
HCV Genotype 1
AASLD gratefully acknowledges support for the
AASLD/LIFER Award from the Liver Institute and
Foundation for Education and Research (LIFER).
AASLD is also providing support for this program
from its own operating funds.
AASLD Career Development
Award in Liver Transplantation
In Memory of the University of
Michigan Transplant Team
A two-year award of $90,000 ($45,000/year)
designed to foster career development for an
individual performing clinical and/or translational
research in the field of liver transplantation and who
has shown commitment to excellence in the field at
an early stage in their career.
2011 Recipient
Christopher Sonnenday, MD, MHS
The University of Michigan,
Ann Arbor, Michigan
Mentor: Robert Merion, MD
AASLD acknowledges funding for the 2011 Career
Development Award is made possible through an
independent grant from Astellas USA Foundation
and donors to the New Challenges–New Solutions
Campaign and The AASLD Liver Research Fund.
AASLD Advanced/Transplant
Hepatology Fellowship
Provides $60,000 in salary and benefit support for
gastroenterology fellows pursuing an additional
full-year of training focused on patient care in
hepatology; including liver transplantation, and
hepatology research.
2011 Recipients
Ranjeeta Bahirwani, MD, BA
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Mentor: K. Rajender Reddy, MD
Research Presented:
• Poster (PI): Chronic Kidney Disease (CKD)
after Liver Transplantation in HIV positive/
HCV positive versus HIV positive/HCV negative
Recipients: Results from the NIH Multi-
Site Study
2011 AASLD Advanced/Transplant Hepatology Fellowship recipients
Devina Bhasin, MD
Mount Sinai School of Medicine
New York, New York
Mentor: Scott Friedman, MD
8
american association for the study of liver diseases